Pedulla Denise E 4
4 · NEOGENOMICS INC · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Pedulla Denise E
General Counsel
Transactions
- Sale
Common Stock
2020-11-10$42.00/sh−2,262$95,004→ 56,726 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-10−15,000→ 0 totalExercise: $7.85Exp: 2020-12-08→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-11-10$7.85/sh+15,000$117,750→ 58,988 total
Holdings
- 25,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (25,000 underlying) - 48,334
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (48,334 underlying) - 17,496
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (17,496 underlying) - 18,757
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (18,757 underlying)
Footnotes (5)
- [F1]On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vested ratably over the first four anniversary dates of the grant date.
- [F2]On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.